Semaglutide 5mg: Complete Research Product Guide

Semaglutide 5mg Research Peptide, Semaglutide is a long-acting GLP-1 receptor agonist being studied for its effects on metabolism, weight regulation, and cellular protection. This guide provides researchers with comprehensive product information, technical specifications, and research applications for semaglutide 5mg.

What Is Semaglutide?

Semaglutide is a synthetic analog of human glucagon-like peptide-1 (GLP-1) with structural modifications that extend its half-life and enhance receptor binding affinity. It is a 31-amino-acid peptide linked by peptide bonds.

Key Product Identifiers

Mechanism of Action

Semaglutide acts as a selective GLP-1 receptor agonist with high binding affinity :

5mg Product Specifications

What’s Included

Research-grade semaglutide is supplied as a lyophilized (freeze-dried) powder in vials containing 5mg of peptide.

How Many Doses in a 5mg Vial?

A 5mg vial contains enough peptide for multiple research doses. Standard clinical protocols use stepwise dose escalation :

The dose escalation schedule most commonly follows a four-week progression: 0.25mg for weeks one through four, then 0.5mg for weeks five through eight, continuing upward until reaching therapeutic maintenance levels. This gradual titration helps minimize gastrointestinal side effects while allowing the body to adapt.

Reconstitution Information

Semaglutide is not soluble in water at neutral pH. Use appropriate solvents for reconstitution :

Research Applications

Semaglutide is being investigated across multiple research areas :

Metabolic Research

In diet-induced obesity (DIO) mouse models, semaglutide demonstrated dose-dependent weight reduction :

Cardioprotection Research

In doxorubicin-induced cardiac toxicity models :

• Semaglutide (12 μg/kg/day for 6 weeks) significantly improved cardiac function

• Reduced myocardial injury markers

• Increased mouse survival rates

• Inhibited oxidative stress and repaired mitochondrial dysfunction

Neuroprotection Research

In a 6-OHDA-induced Parkinson’s disease rat model :

• Semaglutide (25 nmol/kg, once every 2 days for 31 days) significantly improved neurological damage

In Vitro Research

In SH-SY5Y cells treated with 6-OHDA :

• Semaglutide (1-100 nM) significantly reversed oxidative damage

• Demonstrates concentration-dependent cytoprotective effects

Quality Considerations

Research-Grade Standards

Premium semaglutide research products should include:

• HPLC purity analysis (≥98-99%) 

• Mass spectrometry verification of molecular weight ( 4114 Da) 

• Third-party testing documentation

Storage Guidelines

Proper storage is critical for maintaining peptide integrity :

• Lyophilized powder: Store at -20°C for up to 3 years

• Reconstituted solution: Store at -80°C for up to 1 year

• Protect from: Moisture, light, and repeated freeze-thaw cycles

Research Considerations

Compounded Products

Higher-concentration formulations like 5mg are often compounded by licensed pharmacies and require explicit provider oversight. These compounded versions offer dosing flexibility but may lack the full regulatory approval pathway of FDA-approved products.

Individual Variation

Research shows semaglutide efficacy and tolerability vary significantly between individuals based on factors including :

• Genetic variation in GLP-1 receptor expression

• Baseline metabolic rate

• Concurrent medication interactions

Genetic predisposition affecting GLP-1 pathway sensitivity may influence receptor density and glucose homeostasis responsiveness.

Summary of Key Research Applications